Download presentation
Presentation is loading. Please wait.
Published bySherman Park Modified over 6 years ago
1
Technology Commercialization & Industry Partnering
The Neilson Society November 7, 2017 Michael Villalobos, Ph.D. Manager, Biotech Licensing Thomas Utley, Ph.D. Licensing Officer
2
Overview Do I have something of value? How do I protect/retain that value? What is my path to market?
3
Underlying Concept RISK VALUE
4
Commercialization Process
5
Risks Types of Risks IP Technology Regulatory Reimbursement Market
6
Risks Majority of university inventions are near PoC stage
Many not tested outside of creator base Records may not be FDA compliant Final product may not have freedom to operate Technology failure possible Unknown in-house competitive technologies After all this there are business risks
7
Value Technology Risks Stage of Development Concept Proof of concept
Prototype developed Therapeutic molecule identified Validation ex-vivo in-vivo Customer acceptance / Clinical data Value
8
Advancing Development
Collaborate with colleagues Hire contract development firm Ask colleagues or TTO for references Look at university and private contractors Collaborate with a corporation Publish to attract attention
9
Market Dynamics Total market v. Addressable market
Who will actually use the product? Size (e.g. affected patient pop.) Does the size justify the invention? Penetration What is realistic? Are you really going to steal market share?
10
Market Dynamics Competitive Environment Products & companies
Strategic partners Technologies in development Companies Universities
11
Additional Risks Regulatory Impact Pricing
Medical Device / Diagnostics: Class I-III / RUO, CLIA, CDRH Pharmaceuticals / Biologics: CDER, CBER Nutraceuticals: OTC/DTC Agricultural: EPA Pricing Payor reimbursement Established CPT code? Direct-to-consumer
12
Risk Profiles Characterization of Risk Product Technology
Existing Customer Demand Startup Very Low Risk Pre-existing Incremental improvement Yes No Low Risk Pre-existing, New features Moderate Risk New High Risk Very High Risk Extremely High Risk
13
Contractual Fences CDA/NDAs MTAs Co-Development Agreements
Protect trade secrets and know-how Should be defined in scope Retains patent rights MTAs Controls use of a material & its distribution Co-Development Agreements Usually contains an MTA and CDA Defines contribution of the parties Determines benefit sharing
14
Paths to Market Asset Sale
15
Paths to Market License Form Newco Asset Sale
Patents, know-how and prototypes Co-development Agreements Form Newco Sell product Development company - Seek strategic partner Asset Sale Upfont cash Milestone Payments
16
License Structures License Agreement Co-development Deals
Upfront Fee Patent expenses Diligence events Milestone Payments Royalty on net sales Co-development Deals Sponsored Research
17
Alternative License Structures
Standstill Agreement 1-3 months Allows analysis of the business opportunity Option Agreement 3-12 months Option fee ($ ,000) Patent expense reimbursement Allows PoC or validation of the technology
Similar presentations
© 2025 SlidePlayer.com. Inc.
All rights reserved.